A family of aspartic proteases and a novel, dynamic and cell-cycle-dependent protease localization in the secretory pathway of toxoplasma gondii

Traffic

Volumn 8, Issue 8, 2007, Pages 1018-1034

  Shea, Michael ^a,b   Jäkle, Ursula ^c   Liu, Qing ^d   Berry, Colin ^e   Joiner, Keith A ^f   Soldati Favre, Dominique ^a  

^a UNIVERSITY OF GENEVA   (Switzerland)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

^c UNIVERSITY OF HEIDELBERG   (Germany)

^d YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e CARDIFF UNIVERSITY   (United Kingdom)

^f UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

Author keywords

Aspartyl proteinase; Parasite; Plasmepsin; Targeting; Toxoplasma gondii

Indexed keywords

ASPARTIC PROTEINASE; ASPARTIC PROTEINASE 1; ASPARTIC PROTEINASE 2; ASPARTIC PROTEINASE 3; ASPARTIC PROTEINASE 4; ASPARTIC PROTEINASE 5; ASPARTIC PROTEINASE 6; ASPARTIC PROTEINASE 7; COMPLEMENTARY DNA; UNCLASSIFIED DRUG; VIRULENCE FACTOR;

APICOMPLEXA; ARTICLE; CELL CYCLE; CELL DIVISION; CELL MEMBRANE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DAUGHTER CELL; DNA SEQUENCE; ENZYME LOCALIZATION; ENZYME RELEASE; MOLECULAR PHYLOGENY; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; SECRETORY GRANULE; SEQUENCE ALIGNMENT; TOXOPLASMA GONDII;

AMINO ACID SEQUENCE; ANIMALS; ASPARTIC ENDOPEPTIDASES; CELL CYCLE; CERCOPITHECUS AETHIOPS; MOLECULAR SEQUENCE DATA; MULTIGENE FAMILY; TOXOPLASMA; VERO CELLS;

EID: 34447499026     PISSN: 13989219     EISSN: 16000854     Source Type: Journal    
DOI: 10.1111/j.1600-0854.2007.00589.x     Document Type: Article

References (48)

1. Joiner KA, Roos DS. Secretory traffic in the eukaryotic parasite Toxoplasma gondii: Less is more. J Cell Biol 2002; 157: 557-563.
2. Hill D, Dubey JP. Toxoplasma gondii: Transmission, diagnosis and prevention. Clin Microbiol Infect 2002; 8: 634-640.
3. Aspinall TV, Joynson DH, Guy E, Hyde JE, Sims PF. The molecular basis of sulfonamide resistance in Toxoplasma gondii and implications for the clinical management of toxoplasmosis. J Infect Dis 2002; 185: 1637-1643.
4. Wlodawer A, Vondrasek J. Inhibitors of HIV-1 protease: A major success of structure-assisted drug design. Annu Rev Biophys Biomol Struct 1998; 27: 249-284.
5. Hoegl L, Korting HC, Klebe G. Inhibitors of aspartic proteases in human diseases: Molecular modeling comes of age. Pharmazie 1999; 54: 319-329.
6. Coombs GH, Goldberg DE, Klemba M, Berry C, Kay J, Mottram JC. Aspartic proteases of Plasmodium falciparum and other parasitic protozoa as drug targets. Trends Parasitol 2001; 17: 532-537.
7. Nezami A, Kimura T, Hidaka K, Kiso A, Liu J, Kiso Y, Goldberg DE, Freire E. High-affinity inhibition of a family of Plasmodium falciparum proteases by a designed adaptive inhibitor. Biochemistry 2003; 42: 8459-8464.
8. Ersmark K, Feierberg I, Bjelic S, Hamelink E, Hackett F, Blackman MJ, Hulten J, Samuelsson B, Aqvist J, Hallberg A. Potent inhibitors of the Plasmodium falciparum enzymes plasmepsin I and II devoid of cathepsin D inhibitory activity. J Med Chem 2004; 47: 110-122.
9. Liu J, Istvan ES, Gluzman IY, Gross J, Goldberg DE. Plasmodium falciparum ensures its amino acid supply with multiple acquisition pathways and redundant proteolytic enzyme systems. Proc Natl Acad Sci U S A 2006; 103: 8840-8845.
10. Dunn BM. Structure and mechanism of the pepsin-like family of aspartic peptidases. Chem Rev 2002; 102: 4431-4458.
11. Jean L, Long M, Young J, Pery P, Tomley F. Aspartyl proteinase genes from apicomplexan parasites: Evidence for evolution of the gene structure. Trends Parasitol 2001; 17: 491-498.
12. Wu Y, Wang X, Liu X, Wang Y. Data-mining approaches reveal hidden families of proteases in the genome of malaria parasite. Genome Res 2003; 13: 601-616.
13. Banerjee R, Liu J, Beatty W, Pelosof L, Klemba M, Goldberg DE. Four plasmepsins are active in the Plasmodium falciparum food vacuole, including a protease with an active-site histidine. Proc Natl Acad Sci U S A 2002; 99: 990-995.
14. Bozdech Z, Llinas M, Pulliam BL, Wong ED, Zhu J, DeRisi JL. The transcriptome of the intraerythrocytic developmental cycle of Plasmodium falciparum. PLoS Biol 2003; 1: E5.
15. Bernstein NK, Cherney MM, Loetscher H, Ridley RG, James MN. Crystal structure of the novel aspartic proteinase zymogen proplasmepsin II from Plasmodium falciparum. Nat Struct Biol 1999; 6: 32-37.
16. Madabushi A, Chakraborty S, Fisher SZ, Clemente JC, Yowell C, Agbandje-McKenna M, Dame JB, Dunn BM, McKenna R. Crystallization and preliminary X-ray analysis of the aspartic protease plasmepsin 4 from the malarial parasite Plasmodium malariae. Acta Crystallograph Sect F Struct Biol Cryst Commun 2005; 61: 228-231.
17. Abdel-Rahman HM, Kimura T, Hidaka K, Kiso A, Nezami A, Freire E, Hayashi Y, Kiso Y. Design of inhibitors against HIV, HTLV-I, and Plasmodium falciparum aspartic proteases. Biol Chem 2004; 385: 1035-1039.
18. Dell'Agli M, Parapini S, Galli G, Vaiana N, Taramelli D, Sparatore A, Liu P, Dunn BM, Bosisio E, Romeo S. High antiplasmodial activity of novel plasmepsins I and II inhibitors. J Med Chem 2006; 49: 7440-7449.
19. Omara-Opyene AL, Moura PA, Sulsona CR, Bonilla JA, Yowell CA, Fujioka H, Fidock DA, Dame JB. Genetic disruption of the Plasmodium falciparum digestive vacuole plasmepsins demonstrates their functional redundancy. J Biol Chem 2004; 279: 54088-54096.
20. Liu J, Gluzman IY, Drew ME, Goldberg DE. The role of Plasmodium falciparum food vacuole plasmepsins. J Biol Chem 2005; 280: 1432-1437.
21. Klemba M, Goldberg DE. Characterization of plasmepsin V, a membrane-bound aspartic protease homolog in the endoplasmic reticulum of Plasmodium falciparum. Mol Biochem Parasitol 2005; 143: 183-191.
22. Florens L, Washburn MP, Raine JD, Anthony RM, Grainger M, Haynes JD, Moch JK, Muster N, Sacci JB, Tabb DL, Witney AA, Wolters D, Wu Y, Gardner MJ, Holder AA et al. A proteomic view of the Plasmodium falciparum life cycle. Nature 2002; 419: 520-526.
23. Jean L, Grosclaude J, Labbe M, Tomley F, Pery P. Differential localisation of an Eimeria tenella aspartyl proteinase during the infection process. Int J Parasitol 2000; 30: 1099-1107.
24. Jean L, Pery P, Dunn P, Bumstead J, Billington K, Ryan R, Tomley F. Genomic organisation and developmentally regulated expression of an apicomplexan aspartyl proteinase. Gene 2001; 262: 129-136.
25. Francis SE, Banerjee R, Goldberg DE. Biosynthesis and maturation of the malaria aspartic hemoglobinases plasmepsins I and II. J Biol Chem 1997; 272: 14961-14968.
26. Vassar R, Bennett BD, Babu-Khan S, Kahn S, Mendiaz EA, Denis P, Teplow DB, Ross S, Amarante P, Loeloff R, Luo Y, Fisher S, Fuller J, Edenson S, Lile J et al. Beta-secretase cleavage of Alzheimer's amyloid precursor protein by the transmembrane aspartic protease BACE. Science 1999; 286: 735-741.
27. Radke JR, Behnke MS, Mackey AJ, Radke JB, Roos DS, White MW. The transcriptome of Toxoplasma gondii. BMC Biol 2005; 3: 26.
28. Laurent-Matha V, Derocq D, Prebois C, Katunuma N, Liaudet-Coopman E. Processing of human cathepsin D is independent of its catalytic function and auto-activation: Involvement of cathepsins L and B. J Biochem (Tokyo) 2006; 139: 363-371.
29. Lippincott-Schwartz J, Yuan LC, Bonifacino JS, Klausner RD. Rapid redistribution of Golgi proteins into the ER in cells treated with brefeldin A: Evidence for membrane cycling from Golgi to ER. Cell 1989; 56: 801-813.
30. Lippincott-Schwartz J, Donaldson JG, Schweizer A, Berger EG, Hauri HP, Yuan LC, Klausner RD. Microtubule-dependent retrograde transport of proteins into the ER in the presence of brefeldin A suggests an ER recycling pathway. Cell 1990; 60: 821-836.
31. Soldati D, Lassen A, Dubremetz JF, Boothroyd JC. Processing of Toxoplasma ROP1 protein in nascent rhoptries. Mol Biochem Parasitol 1998; 96: 37-48.
32. Letourneur F, Klausner RD. A novel di-leucine motif and a tyrosine-based motif independently mediate lysosomal targeting and endocytosis of CD3 chains. Cell 1992; 69: 1143-1157.
33. Marks MS, Woodruff L, Ohno H, Bonifacino JS. Protein targeting by tyrosine- and di-leucine-based signals: Evidence for distinct saturable components. J Cell Biol 1996; 135: 341-354.
34. Dame JB, Yowell CA, Omara-Opyene L, Carlton JM, Cooper RA, Li T. Plasmepsin 4, the food vacuole aspartic proteinase found in all Plasmodium spp. infecting man. Mol Biochem Parasitol 2003; 130: 1-12.
35. Sargeant TJ, Marti M, Caler E, Carlton JM, Simpson K, Speed TP, Cowman AF. Lineage-specific expansion of proteins exported to erythrocytes in malaria parasites. Genome Biol 2006; 7: R12.
36. LaCount DJ, Vignali M, Chettier R, Phansalkar A, Bell R, Hesselberth JR, Schoenfeld LW, Ota I, Sahasrabudhe S, Kurschner C, Fields S, Hughes RE. A protein interaction network of the malaria parasite Plasmodium falciparum. Nature 2005; 438: 103-107.
37. Bonifacino JS, Dell'Angelica EC. Molecular bases for the recognition of tyrosine-based sorting signals. J Cell Biol 1999; 145: 923-926.
38. Hoppe HC, Ngo HM, Yang M, Joiner KA. Targeting to rhoptry organelles of Toxoplasma gondii involves evolutionarily conserved mechanisms. Nat Cell Biol 2000; 2: 449-456.
39. Karsten V, Hegde RS, Sinai AP, Yang M, Joiner KA. Transmembrane domain modulates sorting of membrane proteins in Toxoplasma gondii. J Biol Chem 2004; 279: 26052-26057.
40. Hu K, Mann T, Striepen B, Beckers CJ, Roos DS, Murray JM. Daughter cell assembly in the protozoan parasite Toxoplasma gondii. Mol Biol Cell 2002; 13: 593-606.
41. Gaskins E, Gilk S, DeVore N, Mann T, Ward G, Beckers C. Identification of the membrane receptor of a class XIV myosin in Toxoplasma gondii. J Cell Biol 2004; 165: 383-393.
42. Meissner M, Schluter D, Soldati D. Role of Toxoplasma gondii myosin A in powering parasite gliding and host cell invasion. Science 2002; 298: 837-840.
43. Soldati D, Boothroyd JC. Transient transfection and expression in the obligate intracellular parasite Toxoplasma gondii. Science 1993; 260: 349-352.
44. Donald RG, Carter D, Ullman B, Roos DS. Insertional tagging, cloning, and expression of the Toxoplasma gondii hypoxanthine-xanthine-guanine phosphoribosyltransferase gene. Use as a selectable marker for stable transformation. J Biol Chem 1996; 271: 14010-14019.
45. Donald RG, Roos DS. Stable molecular transformation of Toxoplasma gondii: A selectable dihydrofolate reductase-thymidylate synthase marker based on drug-resistance mutations in malaria. Proc Natl Acad Sci U S A 1993; 90: 11703-11707.
46. Bastin P, Bagherzadeh Z, Matthews KR, Gull K. A novel epitope tag system to study protein targeting and organelle biogenesis in Trypanosoma brucei. Mol Biochem Parasitol 1996; 77: 235-239.
47. Gunther K, Tummler M, Arnold HH, Ridley R, Goman M, Scaife JG, Lingelbach K. An exported protein of Plasmodium falciparum is synthesized as an integral membrane protein. Mol Biochem Parasitol 1991; 46: 149-157.
48. Meissner M, Reiss M, Viebig N, Carruthers VB, Toursel C, Tomavo S, Ajioka JW, Soldati D. A family of transmembrane microneme proteins of Toxoplasma gondii contain EGF-like domains and function as escorters. J Cell Sci 2002; 115: 563-574.